| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2018 | Raab Michael56 | Director | Sale+OE | 5,000 | $14.41 | $72,057.50 | -46.2% | |
| Apr 12, 2018 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $14.72 | $73,602.00 | -5.5% | |
| Apr 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Sale+OE | 5,000 | $14.27 | $71,343.00 | -11.0% | |
| Apr 2, 2018 | Baird William D III | Chief Financial Officer | Sale+OE | 10,000 | $14.26 | $142,648.00 | -7.8% | |
| Mar 12, 2018 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $15.05 | $75,252.50 | -5.5% | |
| Mar 9, 2018 | Quimi Daphne58 | SVP, Finance | Sale+OE | 8,750 | $15.00 | $131,250.00 | -12.0% | |
| Mar 5, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 335,827 | $13.56 | $4,553,814.12 | +1.9% | |
| Mar 2, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 100,000 | $13.90 | $1,389,500.00 | +0.6% | |
| Mar 1, 2018 | Quimi Daphne58 | SVP, Finance | Sale+OE | 8,149 | $14.06 | $114,536.64 | -11.2% | |
| Mar 1, 2018 | Perceptive Advisors LLC51 | 10% Owner | Buy | 100,000 | $13.69 | $1,369,000.00 | +0.6% |